Resistance of Schistosoma mansoni to praziquantel: is there a problem?

Appleton, 2001, Praziquantel—quality, dosages and markers of resistance, Parasitology Today, 17, 356 Bennett, 1997, The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel, Experimental Parasitology, 87, 260, 10.1006/expr.1997.4229 Butterworth, 1991, Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya—effects on human infection and morbidity, Parasitology, 103, 339, 10.1017/S0031182000059850 Cioli, 1998, Chemotherapy of schistosomiasis: an update, Parasitology Today, 14, 418, 10.1016/S0169-4758(98)01323-4 Cioli, 2000, Praziquantel: is there real resistance and are there alternatives?, Current Opinion in Infectious Diseases, 13, 659, 10.1097/00001432-200012000-00014 Cioli, 1993, Drug-resistance in schistosomes, Parasitology Today, 9, 162, 10.1016/0169-4758(93)90138-6 Coles, 2002, Drug resistance or tolerance in schistosomes?, Trends in Parasitology, 18, 294, 10.1016/S1471-4922(02)02315-2 Coles, G. C. (in press). The sustainable use of anthelmintics in grazing animals. Veterinary Record. Coles, 1997, Defining resistance in Schistosoma, Parasitology Today, 13, 157, 10.1016/S0169-4758(97)89815-8 Coles, 1987, Tolerance of Kenyan Schistosoma mansoni to oxamniquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 782, 10.1016/0035-9203(87)90032-0 Correa-Oliveira, 2000, Natural versus drug-induced resistance in Schistosoma mansoni infection, Parasitology Today, 16, 397, 10.1016/S0169-4758(00)01740-3 Dansio-Appiah, 2002, The interpretation of low praziquantel cure rates in population treatment of Schistosoma mansoni infection, Trends in Parasitology, 18, 125, 10.1016/S1471-4922(01)02209-7 Doenhoff, 1998, Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance, Parasitology Today, 14, 434, 10.1016/S0169-4758(98)01315-5 Doenhoff, 1987, Evidence of an immune-dependent action of praziquantel on Schistosoma mansoni in mice, Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 947, 10.1016/0035-9203(87)90360-9 Doenhoff, 2000, Praziquantel and the control of schistosomiasis, Parasitology Today, 16, 364, 10.1016/S0169-4758(00)01749-X El-Khoby, 1998, The USAID Government of Egypt's Schistosomiasis Research Project (SRP), Parasitology Today, 14, 92, 10.1016/S0169-4758(97)01206-4 Fallon, 1994, Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug-specific, American Journal of Tropical Medicine and Hygiene, 51, 83, 10.4269/ajtmh.1994.51.83 Fallon, 1995, Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni, American Journal of Tropical Medicine and Hygiene, 53, 61, 10.4269/ajtmh.1995.53.61 Fallon, 1996, Schistosome resistance to praziquantel: fact or artifact, Parasitology Today, 12, 316, 10.1016/0169-4758(96)10029-6 Fallon, 1997, Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates, Experimental Parasitology, 86, 29, 10.1006/expr.1997.4149 Geerts, 2000, Drug resistance in human helminths: current situation and lessons from livestock, Clinical Microbiology Reviews, 13, 207, 10.1128/CMR.13.2.207-222.2000 Gryseels, 1994, Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal, Tropical and Geographical Medicine, 46, 209 Gryseels, 2002, Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence, Tropical Medicine and International Health, 6, 864, 10.1046/j.1365-3156.2001.00811.x Guisse, 1997, Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal, American Journal of Tropical Medicine and Hygiene, 56, 511, 10.4269/ajtmh.1997.56.511 Ismail, 1996, Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel, American Journal of Tropical Medicine and Hygiene, 55, 214, 10.4269/ajtmh.1996.55.214 Ismail, 1999, Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers, American Journal of Tropical Medicine and Hygiene, 60, 932, 10.4269/ajtmh.1999.60.932 Katz, 1973, Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas, Revista da Sociedade Brasileira de Medicina Tropical, 7, 381, 10.1590/S0037-86821973000600008 Katz, 1991, Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of 1st treatment, American Journal of Tropical Medicine and Hygiene, 44, 509, 10.4269/ajtmh.1991.44.509 Kohn, 2001, Schistosome calcium channel β subunits: unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel, Journal of Biological Chemistry, 276, 36873, 10.1074/jbc.C100273200 Kusel, 1999, Praziquantel—its use, cost and possible development of resistance, Parasitology Today, 15, 352, 10.1016/S0169-4758(99)01510-0 Liang, 2000, Detection of praziquantel resistance in schistosomes, Tropical Medicine and International Health, 5, 72, 10.1046/j.1365-3156.2000.00514.x Liang, 2001, In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel, International Journal for Parasitology, 31, 1227, 10.1016/S0020-7519(01)00246-6 Liang, 2001, Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni, Annals of Tropical Medicine and Parasitology, 95, 715, 10.1080/00034980120103270 Martin, 1981, The impact of refugia on the development of thiabendazole resistance in Haemonchus contortus, International Journal for Parasitology, 11, 35, 10.1016/0020-7519(81)90023-0 Mutapi, 2001, Heterogeneities in anti-schistosome humoral responses following chemotherapy, Trends in Parasitology, 17, 518, 10.1016/S1471-4922(01)02118-3 Pereira, 1998, Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni, Parasitology, 117, 63, 10.1017/S003118209800273X Pica-Mattoccia, 1993, Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene, Experimental Parasitology, 77, 445, 10.1006/expr.1993.1104 Piquet, 1998, Efficacy of praziquantel against Schistosoma mansoni in northern Senegal, Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 90, 10.1016/S0035-9203(98)90971-3 Polderman, 1988, Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire, Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 115, 10.1016/0035-9203(88)90282-9 Renganathan, 1998, An international initiative on praziquantel use, Parasitology Today, 14, 390, 10.1016/S0169-4758(98)01310-6 Sabah, 1985, Schistosoma mansoni—reduced efficacy of chemotherapy in infected T-cell-deprived mice, Experimental Parasitology, 60, 348, 10.1016/0014-4894(85)90041-4 Sabah, 1986, Schistosoma mansoni—chemotherapy of infections of different ages, Experimental Parasitology, 61, 294, 10.1016/0014-4894(86)90184-0 Stelma, 1995, Efficacy and side-effects of praziquantel in an epidemic focus of Schistosoma mansoni, American Journal of Tropical Medicine and Hygiene, 53, 167, 10.4269/ajtmh.1995.53.167 Stelma, 1997, Oxamniquine cures Schistosoma mansoni in a focus in which cure rates with praziquantel are unusually low, Journal of Infectious Diseases, 176, 304, 10.1086/517273 Tchuem Tchenté, 2001, The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal, Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 65, 10.1016/S0035-9203(01)90335-9 Tsai, 2000, Randomly-amplified polymorphic DNA (RAPD) polymerase chain reaction assay for determination of Schistosoma mansoni strains sensitive or tolerant to anti-schistosomal drugs, Journal of Parasitology, 86, 146, 10.1645/0022-3395(2000)086[0146:RAPDRP]2.0.CO;2 Van Lieshout, 1999, The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal, American Journal of Tropical Medicine and Hygiene, 61, 760, 10.4269/ajtmh.1999.61.760 Van Wyk, 2001, Refugia—overlooked as perhaps the most potent factor concerning development of anthelmintic resistance, Ondesterpoort Journal of Veterinary Research, 68, 55 William, 2001, Praziquantel-induced tegumental damage is diminished in schistosomes derived from praziquantel-resistant infections, Parasitology, 122, 63, 10.1017/S0031182000007137 William, 2001, Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel, International Journal for Parasitology, 31, 1093, 10.1016/S0020-7519(01)00215-6